HSCS – heartsciences inc. (US:NASDAQ)
Stock Stats
News
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals
HeartSciences (NASDAQ:HSCS) had its price target raised by analysts at Ascendiant Capital Markets from $9.00 to $9.20. They now have a "buy" rating on the stock.
Heart Test Laboratories reports Q2 results [Seeking Alpha]
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
Form 8-K HeartSciences Inc. For: Jan 13
Form 4 HeartSciences Inc. For: Jan 12 Filed by: Bent Bruce
Form 4 HeartSciences Inc. For: Jan 12 Filed by: Wells David R.
Form 4 HeartSciences Inc. For: Dec 22 Filed by: HILZ MARK T
Form 4 HeartSciences Inc. For: Dec 22 Filed by: Watson Danielle
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.